AKT1 and type 2 diabetes mellitus: Other authors have demonstrated the inhibition of ROS production in peripheral blood mononuclear cells from healthy and type 2 diabetic patients following treatment with autologous plasma through the Akt/PKB signaling phosphorylation pathway using luminol-dependent chemiluminescence (Veloso et al., 2008).